Literature DB >> 9590209

Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role.

M Gadina1, L M Stancato, C M Bacon, A C Larner, J J O'Shea.   

Abstract

Binding of IL-2 to its receptor activates several biochemical pathways, but precisely how these pathways are linked is incompletely understood. Here, we report that SHP-2, an SH2-domain containing tyrosine phosphatase, associates with different molecules of the IL-2 signaling cascade. Upon IL-2 stimulation, SHP-2 was coimmunoprecipitated with Grb2 and the p85 subunit of phosphatidylinositol 3-kinase. In contrast, SHP-2 was constitutively associated with JAK1 and JAK3. Finally, SHP-2 expression amplified STAT-dependent transcriptional activation whereas a dominant negative allele inhibited transactivation and the IL-2-induced activation of MAPK (mitogen-activated protein kinase). These results demonstrate the involvement of SHP-2 in multiple pathways of the IL-2 signaling cascade and provide evidence for its positive regulatory role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590209

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

2.  Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.

Authors:  Songshu Meng; Qiu Gui; Qing Xu; Kaixin Lu; Xinan Jiao; Jian Fan; Baoxue Ge; Yuehai Ke; Shengping Zhang; Jie Wu; Chuangui Wang
Journal:  J Mol Cell Biol       Date:  2010-08       Impact factor: 6.216

3.  A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

Authors:  Liang Li; Hardik Modi; Tinisha McDonald; John Rossi; Jiing-Kuan Yee; Ravi Bhatia
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

4.  Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells.

Authors:  O I Stenina; E J Poptic; P E DiCorleto
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 5.  Modulation of CTLA-4 and GITR for cancer immunotherapy.

Authors:  Francesca Avogadri; Jianda Yuan; Arvin Yang; David Schaer; Jedd D Wolchok
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

6.  Src family kinases are required for prolactin induction of cell proliferation.

Authors:  J A Fresno Vara ; M A Cáceres; A Silva; J Martín-Pérez
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

7.  Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).

Authors:  Helen Wheadon; Christine Edmead; Melanie J Welham
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

8.  Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.

Authors:  Mary Arnaud; Rym Mzali; Franck Gesbert; Catherine Crouin; Christine Guenzi; Claudine Vermot-Desroches; John Wijdenes; Geneviève Courtois; Olivier Bernard; Jacques Bertoglio
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

9.  PD-1 tempers Tregs in chronic HCV infection.

Authors:  Henry Radziewicz; Richard M Dunham; Arash Grakoui
Journal:  J Clin Invest       Date:  2009-03       Impact factor: 14.808

Review 10.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.